Antiviral activity and mode of action of propolis extracts and selected compounds

Phytotherapy Research

Volumn 24, Issue SUPPL. 1, 2010, Pages

  Schnitzler, Paul ^a   Neuner, Annett ^a   Nolkemper, Silke ^a   Zundel, Christine ^a   Nowack, Hans ^b   Sensch, Karl Heinz ^b   Reichling, Jürgen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department Research and Development   (Germany)

Author keywords

Antiviral activity; Benzoic acid; Caffeic acid derivates; Chrysin; Galangin; Herpes simplex virus type 1; p coumaric acid; Pinocembrin; Propolis

Indexed keywords

ACICLOVIR; ALCOHOL; BENZOIC ACID; CAFFEIC ACID; CARBOXYLIC ACID DERIVATIVE; CHRYSIN; CINNAMIC ACID; COUMARIC ACID; FLAVONOID; GALANGIN; HEPARIN; PINOCEMBRINE; POLYPHENOL; PROPOLIS; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; AQUEOUS SOLUTION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SELECTIVITY; HERPES SIMPLEX VIRUS 1; IC 50; NONHUMAN; SUSPENSION; VIRUS INFECTION; VIRUS PLAQUE;

ANIMALS; ANTIVIRAL AGENTS; BENZOIC ACID; CAFFEIC ACIDS; CELL LINE; COUMARIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; FLAVONOIDS; HERPESVIRUS 1, HUMAN; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; PROPOLIS;

HERPES; HUMAN HERPESVIRUS 1;

EID: 75749151225     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2868     Document Type: Article

References (35)

1. Abd El Hady FK, Hegazi AG. 2002. Egyptian propolis: 2. Chemical composition, antiviral and antimicrobial activities of East Nile Delta propolis. Z Naturforschung 57c: 386-394.
2. Al-Waili NS. 2005. Clinical and mycological benefits of topical application of honey, olive oil and beeswax in diaper dermatitis. Clin Microbiol Infect 11: 160-163.
3. Amoros M, Lurton E, Boustie J, Girre L, Sauvager F, Cormier M. 1994. Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate. J Nat Prod 57: 644-647.
4. Amoros M, Sauvager F, Girre L, Cormier M. 1992a. In vitro antiviral activity of propolis. Apidologie 23: 231-240.
5. Amoros M, Simoes CMO, Girre L, Sauvager F, Cormier M. 1992b. Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis. J Nat Prod 55: 1732-1740.
6. Banskota AH, Tezuka YT, Kadota S. 2001. Recent progress in pharmacological research of propolis. Phytother Res 15: 561-571.
7. Borrelli F, Maffia P, Pinto L et al. 2002. Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia 73(Suppl. 1): S53-S63.
8. Boyanova L, Gergova G, Nikolov R et al. 2005. Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods. J Med Microbiol 54: 481-483.
9. Burdock GA. 1998. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol 36: 347-363.
10. Cassady KA, Whitley RJ. 1997. New therapeutic approaches to the alphaherpesvirus infection. J Antimicrob Chemother 39: 119-128.
11. Chakrabarti S, Pillay D, Ratcliffe D, Cane PA, Collinghan KE, Milligan DW. 2000. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance. J Infect Dis 181: 2055-2058.
12. Cheshenko N, Herold BC. 2002. Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread. J Gen Virol 83: 2247-2255.
13. Cohen HA, Varsano I, Kahan E, Sarrell E, Uziel Y. 2004. Effectiveness of an herbal preparation containing Echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Ped Adolesc Med 158: 217-221.
14. Debiaggi M, Tateo F, Pagani L, Luini M, Romero E. 1990. Effects of propolis flavonoids on virus infectivity and replication. Microbiologica 13: 207-213.
15. El-khawaga O-AY, Salem TA, Elshal MF. 2003. Protective role of Egyptian propolis against tumor in mice. Clin Chim Acta 338: 11-16.
16. Gonzales R, Corcho I, Remirez D et al. 1995. Hepatoprotective effects of propolis extract on carbon tetrachloride-induced liver injury in rats. Phytother Res 9: 14 -17.
17. Huleihel M, Isanu V. 2002. Anti-herpes simplex virus effect of an aqueous extract of propolis. Isr Med Assoc J 4: 923-927.
18. Ito J, Chang F-R, Wang H-K et al. 2001. Anti-AIDS agents. 48. Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis. J Nat Prod 64: 1278-1281.
19. Kartal M, Yildiz S, Kaya S, Kurucu S, Topcu G. 2003. Antimicrobial activity of propolis samples from two different regions of Anatolia. J Ethnopharmacol 56: 69-73.
20. Koch C, Reichling J, Schneele J, Schnitzler P. 2008. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine 15: 71-78.
21. Koo H, Gomes BPFA, Rosalen PL, Ambrosano GMB, Park YK, Cury JA. 2000. In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens. Arch Oral Biol 45: 141-148.
22. Kujumgiev A, Svetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S. 1999. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol 64: 235-240.
23. Langner E, Schilcher H. 1999. Propolis Qualität und Wirkungen von Propolis bzw Propoliszubereitungen. Dtsch Apoth Ztg 139: 3447-3450.
24. Marcucci MC. 1995. Propolis: Chemical composition, biological properties and therapeutical activity. Apidologie 26: 83-99.
25. Marcucci MC, Ferreres F, Garcia-Viguera C et al. 2001. Phenolic compounds from Brazilian propolis with pharmacological activities. J Ethnopharmacol 74: 105-112.
26. Nahmias A, Kibrick S. 1964. Inhibitory effect of heparin on herpes simplex virus. J Bacteriol 87: 1060-1066.
27. Nakajima Y, Shimazawa M, Mishima S, Hara H. 2007. Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sci 80: 370-377.
28. Papova M, Silici S, Kaftanoglu O, Bankova V. 2005. Antibacterial activity of Turkish propolis and its qualitative and quantitative chemical composition. Phytomedicine 12: 221-228.
29. Russo A, Longo R, Vanella A. 2002. Antioxidant activity of propolis: role of caffeic acid and phenethyl ester and galangin. Fitoterapia 73(Suppl. 1): S21-S29.
30. Scheller S, Dworniczak S, Waldemar-Klimmek K, Rajca M, Tomczyk A, Shani J. 1999. Synergism between ethanolic extract of propolis (EEP) and anti-tuberculosis drugs on growth of mycobacteria. Z Naturforsch 54c: 549-553.
31. Schnitzler P, Koch C, Reichling J. 2007. Susceptibility of drug-resistant clinical HSV-1 strains to essential oils of ginger, thyme, hyssop and sandalwood. Antimicrob Agents Chemother 51: 1859-1862.
32. Serkedjieva J, Manolova N, Bankova V. 1992. Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids). J Nat Prod 55: 294-297.
33. Smith JS, Robinson NJ. 2002. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186(suppl. 1): S3-S28.
34. Stranska R, Schuurman R, Nienhuis E et al. 2005. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 32: 7-18.
35. Vynograd N, Vynograd I, Sosnowski Z. 2000. A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV). Phytomedicine 7: 1-6.